RE/MAX Crushes Q3 Earnings: A Play-by-Play Transcript for All My Fellow Real Estate Nerds!

Welcome to the RE/MAX Holdings Third Quarter 2024 Earnings Conference Call and Webcast! Company Participants: Andy Schulz – Senior Vice President, Investor Relations Erik Carlson – Chief Executive Officer Karri Callahan – Chief Financial Officer Amy Lessinger – President Ward Morrison – President and Chief Executive Officer, Motto Mortgage and wemlo Conference Call Participants: Ryan…

Read More

Attention Investors: Don’t Miss Out on the Xiao-I Corporation Class Action Lawsuit! Wolf Haldenstein Adler Freeman & Herz LLP is Here to Help!

Welcome to the Wolf Haldenstein Blog Federal Securities Class Action Lawsuit Filed Against Xiao-I Corporation New York, Nov. 01, 2024 (GLOBE NEWSWIRE) – Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) has announced that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of…

Read More

PT Bank Rakyat Indonesia Persero Tbk (BKRKY) Q3 2024 Earnings Call Transcript: A Professional, Educated, and Profit-Focused Review for Blog and Reader-Friendly Content

PT Bank Rakyat Indonesia Persero Tbk (BKRKY) Q3 2024 Earnings Call Transcript: A Professional, Educated, and Profit-Focused Review for Blog and Reader-Friendly Content Description PT Bank Rakyat Indonesia (Persero) Tbk (OTCPK:BKRKY) Q3 2024 Results Conference Call took place on October 29, 2024 at 11:00 PM ET. The key company participants included Pak Sunarso (CEO), Pak…

Read More

Unpacking Chart Industries Inc.’s Q3 2024 Earnings Call: Key Takeaways and Insights

Chart Industries, Inc. (NYSE:GTLS) Q3 2024 Earnings Conference Call Recap Company Participants Jill Evanko – Chief Executive Officer Joe Brinkman – Chief Financial Officer Conference Call Participants Eric Stine – Craig-Hallum Marc Bianchi – TD Cowen Ben Nolan – Stifel Martin Malloy – Johnson Rice Pavel Molchanov – Raymond James Manav Gupta – UBS Rob…

Read More

NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for…

Read More